Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1612943

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1612943

Chikungunya Market by Type (Diagnosis, Treatment), End-Users (Diagnostic Centers, Hospitals & Clinics, Research Institutions) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 197 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Chikungunya Market was valued at USD 529.33 million in 2023, expected to reach USD 565.11 million in 2024, and is projected to grow at a CAGR of 6.89%, to USD 843.97 million by 2030.

Chikungunya, a mosquito-borne viral disease, has been increasingly recognized as a public health concern due to sporadic outbreaks and its associated debilitating joint pain. The scope of this market research encompasses the epidemiology, prevention, treatment, and management strategies for chikungunya, alongside monitoring vaccine and therapeutic developments. The necessity for comprehensive market analysis lies in the global health burden posed by chikungunya, driving demand for effective vaccines and anti-viral drugs. Application and end-use span across pharmaceuticals, healthcare institutions, public health policy frameworks, and vector control mechanisms. Key growth influencers include rising awareness, government funding for research, and technological advancements in mosquito control. The potential market opportunity is magnified by the expanding geographic range of Aedes mosquitoes and increasing incidences of disease outbreaks in tropical and subtropical regions. However, market growth faces limitations such as insufficient infrastructure in low-income regions, the complexities of vaccine development, and competition with other mosquito-borne disease priorities like dengue and malaria.

KEY MARKET STATISTICS
Base Year [2023] USD 529.33 million
Estimated Year [2024] USD 565.11 million
Forecast Year [2030] USD 843.97 million
CAGR (%) 6.89%

Moreover, cultural and logistical challenges in vaccine distribution and public acceptance of new products may hinder market penetration. Opportunities for innovation and research lie in developing cost-effective and scalable vector control solutions, advancing vaccine trials, and improving therapeutic interventions to alleviate symptoms. Research focusing on genetic editing to reduce mosquito fertility or transmissibility could be transformative. Furthermore, creating mobile health technologies for early detection and telemedicine consultations can augment disease management efficiency. The chikungunya market exhibits cyclic demand patterns, often spiking during outbreaks, and is influenced by factors like travel and climate change, suggesting a need for adaptive market strategies. Businesses can capitalize on collaborations with local health authorities and investing in awareness programs to enhance product uptake. Strategic partnerships in research and development can further accelerate novel solution rollouts, catering to both endemic and emergent markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chikungunya Market

The Chikungunya Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased prevalence of chikungunya virus globally
    • Supportive international health regulations and policies by regulatory bodies
    • Increasing government and non-government initiatives to raise awareness
  • Market Restraints
    • High costs associated with research and development
  • Market Opportunities
    • Advancements in diagnostic techniques and treatment options for Chikungunya
    • Integration of telemedicine services for remote care to manage Chikungunya
  • Market Challenges
    • Complexities in vaccine development and manufacturing for Chikungunya

Porter's Five Forces: A Strategic Tool for Navigating the Chikungunya Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chikungunya Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chikungunya Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chikungunya Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chikungunya Market

A detailed market share analysis in the Chikungunya Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chikungunya Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chikungunya Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chikungunya Market

A strategic analysis of the Chikungunya Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chikungunya Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BioMedomics Inc., Cellex, Inc., Chembio Diagnostic Systems, Inc. by Biosynex, Creative Diagnostics, ELITechGroup by Bruker Corporation, Eurofins Scientific Ltd., F. Hoffmann La-Roche Ltd, Grifols Diagnostic Solutions Inc., Immucor, Inc., Quest Diagnostics, Randox Laboratories Ltd., Serological Research Institutes, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Chikungunya Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnosis and Treatment. The Diagnosis is further studied across Serological Tests and Viral Detection Tests.
  • Based on End-Users, market is studied across Diagnostic Centers, Hospitals & Clinics, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-CD5A9334D93F

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased prevalence of chikungunya virus globally
      • 5.1.1.2. Supportive international health regulations and policies by regulatory bodies
      • 5.1.1.3. Increasing government and non-government initiatives to raise awareness
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in diagnostic techniques and treatment options for Chikungunya
      • 5.1.3.2. Integration of telemedicine services for remote care to manage Chikungunya
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in vaccine development and manufacturing for Chikungunya
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising R&D toward development of next generation treatment for chikungunya
    • 5.2.2. End-Users: Coolab
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chikungunya Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnosis
    • 6.2.1. Serological Tests
    • 6.2.2. Viral Detection Tests
  • 6.3. Treatment

7. Chikungunya Market, by End-Users

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals & Clinics
  • 7.4. Research Institutions

8. Americas Chikungunya Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Chikungunya Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Chikungunya Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FDA Approval of Ixchiq: A New Vaccine Against Chikungunya for High-Risk Adults
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Beckman Coulter, Inc.
  • 3. Becton, Dickinson and Company (BD)
  • 4. BioMedomics Inc.
  • 5. Cellex, Inc.
  • 6. Chembio Diagnostic Systems, Inc. by Biosynex
  • 7. Creative Diagnostics
  • 8. ELITechGroup by Bruker Corporation
  • 9. Eurofins Scientific Ltd.
  • 10. F. Hoffmann La-Roche Ltd
  • 11. Grifols Diagnostic Solutions Inc.
  • 12. Immucor, Inc.
  • 13. Quest Diagnostics
  • 14. Randox Laboratories Ltd.
  • 15. Serological Research Institutes
  • 16. Thermo Fisher Scientific, Inc.
Product Code: MRR-CD5A9334D93F

LIST OF FIGURES

  • FIGURE 1. CHIKUNGUNYA MARKET RESEARCH PROCESS
  • FIGURE 2. CHIKUNGUNYA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHIKUNGUNYA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHIKUNGUNYA MARKET DYNAMICS
  • TABLE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHIKUNGUNYA MARKET SIZE, BY VIRAL DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHIKUNGUNYA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHIKUNGUNYA MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!